Home/Aptadir/Annalisa Di Ruscio, MD, PhD

AD

Annalisa Di Ruscio, MD, PhD

Founder

Therapeutic Areas

Oncology Rare Diseases

Aptadir Pipeline

Drug	Indication	Phase
MDS Program	Myelodysplastic Neoplasms (MDS)	Pre-clinical

Leadership Team at Aptadir

Giovanni Amabile, PhD

Executive Chairman

Vittorio De Franciscis, PhD

Daniel G. Tenen, MD

Marcin Kortylewski, PhD

View full Aptadir profile